Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 16
2004 21
2005 4
2006 14
2007 14
2008 25
2009 19
2010 15
2011 14
2012 19
2013 22
2014 30
2015 28
2016 9
2017 16
2018 16
2019 23
2020 37
2021 37
Text availability
Article attribute
Article type
Publication date

Search Results

330 results
Results by year
Filters applied: . Clear all
Page 1
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
Hussain M, Mateo J, Fizazi K, Saad F, Shore N, Sandhu S, Chi KN, Sartor O, Agarwal N, Olmos D, Thiery-Vuillemin A, Twardowski P, Roubaud G, Özgüroğlu M, Kang J, Burgents J, Gresty C, Corcoran C, Adelman CA, de Bono J; PROfound Trial Investigators. Hussain M, et al. N Engl J Med. 2020 Dec 10;383(24):2345-2357. doi: 10.1056/NEJMoa2022485. Epub 2020 Sep 20. N Engl J Med. 2020. PMID: 32955174 Clinical Trial.
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.
Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, Okajima Y, Kurotobi S, Hirai K, Soga T, Ishiguchi Y, Okuma Y, Takada N, Yanai M, Sato J, Nakayashiro M, Ayusawa M, Yamamoto E, Nomura Y, Hashimura Y, Ouchi K, Masuda H, Takatsuki S, Hirono K, Ariga T, Higaki T, Otsuki A, Terauchi M, Aoyagi R, Sato T, Fujii Y, Fujiwara T, Hanaoka H, Hata A; KAICA trial Investigators. Hamada H, et al. Among authors: fujii y. Lancet. 2019 Mar 16;393(10176):1128-1137. doi: 10.1016/S0140-6736(18)32003-8. Epub 2019 Mar 7. Lancet. 2019. PMID: 30853151 Clinical Trial.
Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.
Tomita Y, Kondo T, Kimura G, Inoue T, Wakumoto Y, Yao M, Sugiyama T, Oya M, Fujii Y, Obara W, Motzer RJ, Uemura H. Tomita Y, et al. Among authors: fujii y. Jpn J Clin Oncol. 2020 Jan 24;50(1):12-19. doi: 10.1093/jjco/hyz132. Jpn J Clin Oncol. 2020. PMID: 31633185 Free PMC article. Clinical Trial.
[Prostate cancer].
Fujii Y, Fukui I. Fujii Y, et al. Gan To Kagaku Ryoho. 2007 Nov;34(11):1740-4. Gan To Kagaku Ryoho. 2007. PMID: 18030007 Review. Japanese.
Undifferentiated prostate cancer treated with docetaxel.
Kobayashi M, Yokoyama M, Inoue M, Fujii Y. Kobayashi M, et al. Among authors: fujii y. IJU Case Rep. 2020 Apr 20;3(4):125-127. doi: 10.1002/iju5.12162. eCollection 2020 Jul. IJU Case Rep. 2020. PMID: 33392469 Free PMC article.
DWI as an Imaging Biomarker for Bladder Cancer.
Yoshida S, Takahara T, Kwee TC, Waseda Y, Kobayashi S, Fujii Y. Yoshida S, et al. Among authors: fujii y. AJR Am J Roentgenol. 2017 Jun;208(6):1218-1228. doi: 10.2214/AJR.17.17798. Epub 2017 Feb 28. AJR Am J Roentgenol. 2017. PMID: 28245143 Review.
Editorial Comment.
Tanaka H, Fujii Y. Tanaka H, et al. Among authors: fujii y. J Urol. 2021 May;205(5):1319-1320. doi: 10.1097/JU.0000000000001549.02. Epub 2021 Feb 24. J Urol. 2021. PMID: 33625924 No abstract available.
330 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page